Business Context and Reporting Period
This Form 8-K Current Report from DaVita HealthCare Partners Inc. (DaVita) covers events occurring on June 17, 2013, specifically the company's annual meeting of stockholders held in Denver, Colorado. The filing details the results of stockholder votes and the approval of amendments to the company's equity incentive plan.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for any financial statement items.
Material Changes and Voting Results
At the annual meeting, 93,902,676 shares (88.78% of outstanding shares) were represented. Key outcomes included:
- Director Elections: All ten nominees were elected. Notable dissent occurred for John M. Nehra (14.6 million votes against) and Peter T. Grauer (4.9 million votes against), while others received significantly fewer "against" votes.
- Equity Plan Amendment: Stockholders approved an amendment to the 2011 Incentive Award Plan, increasing the number of shares available for issuance by 8,500,000. The total maximum shares available under the plan is now 47,178,338.
- Accounting Firm: Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for 2013.
- Executive Compensation: The advisory vote on executive compensation passed with a majority of votes cast (52.2 million for vs. 34.7 million against).
- Stockholder Proposals: Two stockholder proposals were defeated: one regarding executive pay (21.7 million for vs. 65.2 million against) and one regarding lobbying (18.5 million for vs. 57.6 million against).
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, outlook, or specific operational risks. The primary focus is on the administrative completion of the annual meeting and the formalization of the amended equity plan terms.
Investor Verification Checklist
- Verify the specific terms of the amended 2011 Incentive Award Plan (Exhibit 10.1) to understand dilution implications.
- Review the significant "against" votes for directors John M. Nehra and Peter T. Grauer to assess potential governance concerns.
- Confirm the impact of the 8.5 million share increase on the company's total authorized share count and potential future dilution.
- Monitor the outcome of the defeated stockholder proposals regarding executive pay and lobbying for potential future activism.